DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $36.21 million. The enterprise value is $31.30 million.
| Market Cap | 36.21M |
| Enterprise Value | 31.30M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 29.92 million shares outstanding. The number of shares has increased by 24.93% in one year.
| Shares Outstanding | 29.92M |
| Shares Change (YoY) | +24.93% |
| Shares Change (QoQ) | +19.17% |
| Owned by Insiders (%) | 14.16% |
| Owned by Institutions (%) | 29.99% |
| Float | 24.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.90 |
| Forward PS | 0.85 |
| PB Ratio | 0.46 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.39.
| Current Ratio | 2.95 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.80% and return on invested capital (ROIC) is -56.82%.
| Return on Equity (ROE) | -84.80% |
| Return on Assets (ROA) | -52.40% |
| Return on Capital (ROIC) | -56.82% |
| Revenue Per Employee | $64,776 |
| Profits Per Employee | -$203,724 |
| Employee Count | 294 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 2.34 |
Taxes
| Income Tax | -1.93M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.19% in the last 52 weeks. The beta is 1.53, so DarioHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | -66.19% |
| 50-Day Moving Average | 1.35 |
| 200-Day Moving Average | 1.62 |
| Relative Strength Index (RSI) | 43.00 |
| Average Volume (20 Days) | 81,088 |
Short Selling Information
The latest short interest is 1.62 million, so 5.40% of the outstanding shares have been sold short.
| Short Interest | 1.62M |
| Short Previous Month | 1.54M |
| Short % of Shares Out | 5.40% |
| Short % of Float | 6.70% |
| Short Ratio (days to cover) | 19.56 |
Income Statement
In the last 12 months, DarioHealth had revenue of $19.04 million and -$59.90 million in losses. Loss per share was -$1.68.
| Revenue | 19.04M |
| Gross Profit | 5.25M |
| Operating Income | -61.64M |
| Pretax Income | -55.71M |
| Net Income | -59.90M |
| EBITDA | -50.61M |
| EBIT | -55.71M |
| Loss Per Share | -$1.68 |
Balance Sheet
The company has $35.34 million in cash and $30.44 million in debt, giving a net cash position of $4.90 million or $0.16 per share.
| Cash & Cash Equivalents | 35.34M |
| Total Debt | 30.44M |
| Net Cash | 4.90M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 78.03M |
| Book Value Per Share | 2.61 |
| Working Capital | 34.71M |
Cash Flow
In the last 12 months, operating cash flow was -$38.73 million and capital expenditures -$566,000, giving a free cash flow of -$39.30 million.
| Operating Cash Flow | -38.73M |
| Capital Expenditures | -566,000 |
| Free Cash Flow | -39.30M |
| FCF Per Share | -$1.14 |
Margins
Gross margin is 27.56%, with operating and profit margins of -323.65% and -314.51%.
| Gross Margin | 27.56% |
| Operating Margin | -323.65% |
| Pretax Margin | -292.52% |
| Profit Margin | -314.51% |
| EBITDA Margin | -265.73% |
| EBIT Margin | -292.52% |
| FCF Margin | -206.35% |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.93% |
| Shareholder Yield | -24.93% |
| Earnings Yield | -165.42% |
| FCF Yield | -108.54% |
Analyst Forecast
The average price target for DarioHealth is $4.05, which is 234.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.05 |
| Price Target Difference | 234.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 43.95% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 18, 2019. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
DarioHealth has an Altman Z-Score of -4.2 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.2 |
| Piotroski F-Score | 1 |